NOCC “Break the Silence” Campaign
by Jane Langridge
In May 2006 we launched the new face of the National Ovarian Cancer Coalition (NOCC) to expand our reach and capture the attention of today’s women. We’ve designed a new logo, website, and educational materials with a contemporary look and feel to better educate and inform women and their families.
We also launched the Coalition’s first national media campaign called Break the Silence. Based on market research that revealed widespread misconceptions about prevention and diagnosis, our overall goals are to jumpstart public dialogue and increase general knowledge of early signs and symptoms in hopes of improving survival rates. To set the stage and motivate the media to champion our cause, it was essential to provide reporters with hard facts establishing what we all know is true—that knowledge and discussion of ovarian cancer symptoms among women is virtually nonexistent.
As a result of a Break the Silence media tour, campaign messages have reached more than 3.5 million television viewers and interviews from a teleconference have resulted in extensive media coverage. Throughout the summer and fall, popular women’s magazines such as Glamour, Family Circle and Healthy Living will run articles on ovarian cancer.
Ovarian Cancer Awareness month will see the next phase of the Break the Silence campaign with the launch of a national PSA starring NOCC’s first celebrity spokesperson, Eva La Rue, whose grandmother and great-grandmother died of ovarian cancer. Currently, Eva is lead actress on CBS’ hit show CSI: Miami and is a frequent correspondent on the entertainment show Extra. She is best known for her two-time Emmy winning role as Dr. Maria Santos on ABC’s All My Children.
We hope these activities, along with all our other programs, and the activities of our 80 divisions and friends at FORCE, really will help Break the Silence on this deadly disease.
For more information on the Break the Silence campaign and to download a “Conversation Starter” visit ovarian.org.
After serving on the NOCC Board of Directors since 1999, Jane Langridge became Chief Executive Officer in 2005. She has over 20 years of oncology experience from working both in the healthcare sector and the pharmaceutical arena.
Disclaimer: Health links are made available for educational purposes only. This information should not be interpreted as medical advice. All health information should be discussed with your health care provider. Please read our full disclaimer for more information.
This site has been made possible by a generous grant from Morphotek.